)
)
Redwood Pharma Investor Relations Material
Latest events
Access the full event backlog
Slides, Transcripts, and Reports from 11,000+ public companies
Latest reports from Redwood Pharma
Access all reports
Redwood Pharma AB focuses on developing innovative ophthalmic therapies, particularly for dry eye disease (DED). Utilizing its patented IntelliGel technology, the company aims to enhance drug delivery, allowing for reduced dosages and decreased dosing frequency, thus minimizing potential systemic toxicities. Redwood Pharma's strategy involves early-stage clinical development with the intent to license its products to larger pharmaceutical firms for global distribution. Redwood Pharma is headquartered in Stockholm, Sweden, and its shares are listed on the Nasdaq Stockholm.
Latest articles
)
Walmart: Walton, Retailing, and Everyday Low Prices
Walmart was founded in 1962 by Sam Walton, and has grown to become the largest retailer in the world, employing more than 2.1 million people worldwide.
17 Oct 2024
)
Texas Instruments: From Calculators to Master Capital Allocators
Texas Instruments has undergone many transformations from its origins in oil exploration to become one of the world's largest semiconductor producers.
11 Oct 2024
)
The Art of Portfolio Management: Lessons from Tom O'Hara
Tom O'Hara shares insights on stock picking, navigating market distractions, and the importance of one-on-one meetings with management teams.
4 Oct 2024
Ticker symbol
REDW
Country
🇸🇪 Sweden